Related Experiment Video
Updated: May 30, 2026
05:12
Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
Persistent insomnia, abstinence, and moderate drinking in alcohol-dependent individuals
Kirk J Brower1, Amy Krentzman, Elizabeth A R Robinson
1Department of Psychiatry and Addiction Research Center, University of Michigan, 4250 Plymouth Rd., Ann Arbor, MI 48109–2700, USA. kbrower@umich.edu
The American Journal on Addictions
|August 16, 2011
Summary
Insomnia is prevalent in alcohol-dependent patients. While abstinence and moderate drinking can improve sleep, many patients experience persistent insomnia, requiring specialized treatment.
Area of Science:
- Psychiatry
- Sleep Medicine
- Addiction Research
Background:
- Insomnia is a common issue for individuals with alcohol dependence (AD), increasing relapse risk.
- Abstinence is traditionally viewed as the primary method for sleep normalization in AD patients, but its effectiveness varies.
- The prevalence and persistence of insomnia in AD patients and its response to different drinking outcomes require further investigation.
Purpose of the Study:
- To determine the prevalence and predictors of insomnia in alcohol-dependent patients at baseline and over time.
- To examine how sleep problems evolve in response to abstinence, moderate drinking, or relapse after treatment.
- To identify factors associated with persistent insomnia in this population.
Main Methods:
- A naturalistic longitudinal study followed 267 alcohol-dependent patients for 6 months.
- Data collected included insomnia (Sleep Problems Questionnaire), drinking patterns (Time-Line Follow-Back Interview), and psychiatric symptoms (Brief Symptom Inventory).
- Statistical analyses included correlations, logistic regression, and repeated measures ANOVA.
Main Results:
- 47% of patients had insomnia at baseline, predicted by female gender and psychiatric severity.
- Both abstinence and moderate drinking significantly reduced insomnia symptoms.
- Over 60% of patients with baseline insomnia experienced persistent symptoms, particularly those with severe baseline insomnia; one-quarter had persistent insomnia despite abstinence.
Conclusions:
- Treatments focused on preventing heavy drinking can help with insomnia in alcohol-dependent patients.
- However, a significant portion of patients experience persistent insomnia, indicating a need for additional, insomnia-specific interventions.
- Further evaluation and targeted treatment for insomnia are crucial for some alcohol-dependent individuals undergoing substance abuse treatment.
More Related Videos
08:45Modeling Alcohol Consumption in Rodents Using Two-Bottle Choice Home Cage Drinking and Microstructural Analysis
Published on: November 8, 2024
07:31Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
Published on: January 7, 2019
Related Concept Videos
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:24Substance Use Disorders Affecting Sleep
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
01:27Insomnia
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...